Goldman Sachs’s Select Medical SEM Stock Holding History

Goldman Sachs’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,064	Closed	-$112K	–	5977
2018 Q1	$112K	Sell	12,064 -7,981	-40%	-$76K	﹤0.01%	5242
2017 Q4	$191K	Buy	+20,045	New	+$192K	﹤0.01%	5450
2017 Q1	–	Sell	-2,784	Closed	-$20K	–	6979
2016 Q4	$20K	Buy	2,784 +2,413	+650%	+$16.8K	﹤0.01%	6647
2016 Q3	$3K	Sell	371 -1,856	-83%	-$11.8K	﹤0.01%	6948
2016 Q2	$13K	Buy	+2,227	New	+$14.8K	﹤0.01%	6820
2015 Q3	–	Sell	-15,405	Closed	-$134K	–	7470
2015 Q2	$134K	Buy	15,405 +4,455	+41%	+$37.4K	﹤0.01%	6444
2015 Q1	$87K	Buy	10,950 +8,723	+392%	+$65.2K	﹤0.01%	6489
2014 Q4	$17K	Buy	+2,227	New	+$16.2K	﹤0.01%	7002
2014 Q3	–	Sell	-2,227	Closed	-$19K	–	7238
2014 Q2	$19K	Sell	2,227 -444,327	-100%	-$3.44M	﹤0.01%	6886
2014 Q1	$3M	Hold	446,554	–	–	﹤0.01%	3583
2013 Q4	$2.79M	Buy	+446,554	New	+$2.18M	﹤0.01%	3722

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Goldman Sachs's SEM Position: Q2 2026 in Review

Goldman Sachs reduced its Select Medical (SEM) stake by 58% in Q2 2026, selling an estimated $19.9M and leaving 871,540 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Goldman Sachs first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $80.5M in Q2 2021. 241 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Goldman Sachs held 871,540 shares of Select Medical worth $14.4M as of Q2 2026.
Goldman Sachs sold 1,210,343 Select Medical shares in Q2 2026, an estimated $19.9M.
Select Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2948 holding.
Goldman Sachs first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
Goldman Sachs's Select Medical position peaked at $80.5M in Q2 2021.
241 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.